1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. COHANCE LIFESCIENCES LTD.

Cohance Lifesciences Ltd.

NSE: COHANCE | BSE: 543064

Expensive Underperformer
Download real time

1040.00 -39.20 (-3.63%)

73.91% Gain from 52W Low

104.1K NSE+BSE Volume

NSE 19 May, 2025 9:34 AM (IST)

Watchlist

Portfolio

Alert

Share
15S
15W
4O
1T
26,474.8

Market Cap

High in industry
94.8

PE TTM

High in industry
-3.8

PEG TTM

PEG TTM is negative
13.4

Price to Book

High in industry
0.5

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Cohance Lifesciences Ltd. is on 28 May 2025 for the purpose of Audited Results See details

Cohance Lifesciences Ltd. - COHANCE - stock price prediction, stock forecast, target price, analyst ratings from 6 analysts

Cohance Lifesciences Ltd. has a share price target of Rs 1397, revenue growth forecast of 146.0%, and profit growth estimate of 95.0% for FY25, based on top 6 analyst calls.

Forecaster Screeners